摘要
目的:探讨红皮病性银屑病的诱发因素、临床表现及治疗效果。方法:对52例红皮病性银屑病患者进行临床回顾分析。结果:男女发病率之比为4:1,多种因素可诱发或加重红皮病性银屑病,滥用糖皮质激素、中药的不合理治疗以及感染是其主要诱因。结论:合理规范的治疗是影响红皮病性银屑病预后的重要因素。甲氨蝶呤仍是治疗红皮病性银屑病的一线药物,阿维A联合复方甘草甜素(商品名:美能)治疗红皮病性银屑病也有确切疗效。美能作为治疗红皮病性银屑病的联合用药效果良好,值得临床推广应用。
Objective：To analyze the precipitating factors, course and treatment of erythrodermic psoriasis. Methods： We analyzed retrospectively the clinical and laboratory data of 52 patients diagnosed as erythrodermic psoriasis that were treated in our department. Results： Male patients outnumbered female patients in a propotion of 4：1. Systemic corticosteroid, Chinese medicines, and infections were important precipitating factors. Conclusions：Methotrexate is still one of our most effective therapies. Oral acitretin in combination with glycyr rhizin is effective for the treatment of erythrodermic psoriasis.
出处
《临床皮肤科杂志》
CAS
CSCD
北大核心
2006年第8期494-496,共3页
Journal of Clinical Dermatology
关键词
银屑病
红皮病性
psoriasis, erythrodermic
